Overexpression of transcription factor AP-2α suppresses mammary gland growth and morphogenesis

被引:58
作者
Zhang, J
Brewer, S
Huang, J
Williams, T
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Craniofacial Biol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Cell & Struct Biol, Denver, CO 80262 USA
[3] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA
关键词
transcription factors; AP-2; alpha; gamma; transgenic mice; mammary gland; alveolar budding; lobuloalveolar development; breast cancer;
D O I
10.1016/S0012-1606(02)00119-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
AP-2 transcription factors are key regulators of mouse embryonic development. Aberrant expression of these genes has also been linked to the progression of human breast cancer. Here, we have investigated the role of the AP-2 gene family in the postnatal maturation of the mouse mammary gland. Analysis of AP-2 RNA and protein levels demonstrates that these genes are expressed in the mammary glands of virgin and pregnant mice. Subsequently, AP-2 expression declines during lactation and then is reactivated during involution. The AP-2alpha and AP-2gamma proteins are localized in the ductal epithelium, as well as in the terminal end buds, suggesting that they may influence growth of the ductal network. We have tested this hypothesis by targeting AP-2alpha expression to the mouse mammary gland using the MMTV promoter. Our studies indicate that overexpression of AP-2alpha inhibits mammary gland growth and morphogenesis, and this coincides with a rise in PTHrP expression. Alveolar budding is severely curtailed in transgenic virgin mice, while lobuloalveolar development and functional differentiation are inhibited during pregnancy and lactation, respectively. Our studies strongly support a role for the AP-2 proteins in regulating the proliferation and differentiation of mammary gland epithelial cells in both mouse and human. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:127 / 145
页数:19
相关论文
共 69 条
[61]   AP-2α transcription factor is required for early morphogenesis of the lens vesicle [J].
West-Mays, JA ;
Zhang, J ;
Nottoli, T ;
Hagopian-Donaldson, S ;
Libby, D ;
Strissel, KJ ;
Williams, T .
DEVELOPMENTAL BIOLOGY, 1999, 206 (01) :46-62
[62]   CHARACTERIZATION OF A DIMERIZATION MOTIF IN AP-2 AND ITS FUNCTION IN HETEROLOGOUS DNA-BINDING PROTEINS [J].
WILLIAMS, T ;
TJIAN, R .
SCIENCE, 1991, 251 (4997) :1067-1071
[63]   ANALYSIS OF THE DNA-BINDING AND ACTIVATION PROPERTIES OF THE HUMAN TRANSCRIPTION FACTOR AP-2 [J].
WILLIAMS, T ;
TJIAN, R .
GENES & DEVELOPMENT, 1991, 5 (04) :670-682
[64]   CLONING AND EXPRESSION OF AP-2, A CELL-TYPE-SPECIFIC TRANSCRIPTION FACTOR THAT ACTIVATES INDUCIBLE ENHANCER ELEMENTS [J].
WILLIAMS, T ;
ADMON, A ;
LUSCHER, B ;
TJIAN, R .
GENES & DEVELOPMENT, 1988, 2 (12A) :1557-1569
[65]  
WYSOLMERSKI JJ, 1995, DEVELOPMENT, V121, P3539
[66]   AP2 inhibits cancer cell growth and activates p21(WAF1)/(CIP1) expression [J].
Zeng, YX ;
Somasundaram, K ;
ElDeiry, WS .
NATURE GENETICS, 1997, 15 (01) :78-82
[67]   Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 [J].
Zhang, JA ;
HagopianDonaldson, S ;
Serbedzija, G ;
Elsemore, J ;
PlehnDujowich, D ;
McMahon, AP ;
Flavell, RA ;
Williams, T .
NATURE, 1996, 381 (6579) :238-241
[68]   Cloning and characterization of a novel mouse AP-2 transcription factor, Ap-2γ, with unique DNA binding and transactivation properties [J].
Zhao, F ;
Satoda, M ;
Licht, JD ;
Hayashizaki, Y ;
Gelb, BD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :40755-40760
[69]  
ZUTTER MM, 1994, J BIOL CHEM, V269, P463